| Literature DB >> 26876001 |
Ryosuke Saigusa1, Yoshihide Asano1, Kouki Nakamura1, Takashi Yamashita1, Yohei Ichimura1, Takehiro Takahashi1, Tetsuo Toyama1, Takashi Taniguchi1, Ayumi Yoshizaki1, Miki Miyazaki1, Zenshiro Tamaki1, Shinichi Sato1.
Abstract
Systemic sclerosis (SSc) is believed to be caused by a complex interplay between genetic factors and environmental influences. Although silicone has been considered to be a candidate of environmental agents, clinical data presented so far fail to show a significant association between silicone breast implant (SBI) and the development of SSc. Because we recently experienced two consecutive SSc patients with anti-RNA polymerase III (RNAP III) antibody who underwent SBI, we here investigated the association of SBI history with the development of SSc positive for anti-RNAP III antibody. Among 262 Japanese SSc patients, of note, the frequency of SBI history was significantly higher in the anti-RNAP III antibody group (16.0% [4/25]) than in the anti-topoisomerase I antibody group (0% [0/87], P < 0.005) and in the anticentromere antibody group (1.2% [2/150], P < 0.005). These results suggest that SBI could influence the development of SSc in a certain subset of patients with anti-RNAP III antibody.Entities:
Keywords: anti-RNA polymerase III antibody; chronic inflammation; environmental factor; silicone breast implant; systemic sclerosis
Mesh:
Substances:
Year: 2016 PMID: 26876001 DOI: 10.1111/1346-8138.13292
Source DB: PubMed Journal: J Dermatol ISSN: 0385-2407 Impact factor: 4.005